• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Lot Number VMFB230423
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 07/18/2023
Event Type  malfunction  
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
It was reported that thrombosis occurred.A versacross connect access solution was selected for use during a left atrial appendage (laa) closure procedure using watchman fxd curve access system (was).During the procedure, after transseptal had been completed, the physician was about to exchange versacross rf wire for the non-boston scientific pigtail catheter when a thrombus was noticed in the septum.The thrombus was aspirated back through the sheath, and some thrombus was removed, however it was noticed that some was still there.The whole system was removed, and a large thrombus was observed to be on the versacross rf wire.The activated clotting time (act) at the time the thrombus was noticed was at 172 seconds, therefore, the procedure was cancelled.The patient was kept on a heparin drip and was admitted to the hospital overnight for observation.The patient was discharged the next day.No interruption on the irrigation flow.The patient stopped using warfarin 5 days before the procedure, and a full dose of heparin was administered immediately after femoral access, prior to tsp.The device is not expected to be returned for analysis.No other issues were noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17546310
MDR Text Key321121193
Report Number2124215-2023-42488
Device Sequence Number1
Product Code DRE
UDI-Device Identifier00685447012573
UDI-Public00685447012573
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/14/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Lot NumberVMFB230423
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/18/2023
Initial Date FDA Received08/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/26/2023
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
-
-